Hydrogel-based drug delivery systems for enhanced tumor therapy

Area of Science:

• Biomaterials Science
• Oncology
• Drug Delivery Systems

Background:

• Cancer presents significant global health challenges, with existing treatments facing limitations like toxicity and drug resistance.
• The tumor microenvironment (TME) often suppresses effective antitumor responses.
• Hydrogel technology offers a promising platform to address these therapeutic challenges.

Purpose of the Study:

• To review the latest advancements in hydrogel applications for cancer treatment.
• To highlight how hydrogels enhance various antitumor strategies.
• To discuss the potential of hydrogels in overcoming current cancer therapy limitations.

Main Methods:

• Review of innovative hydrogel systems for cancer therapy.
• Analysis of hydrogel properties enabling controlled drug delivery.
• Exploration of hydrogel applications in chemotherapy, immunotherapy, radiotherapy, phototherapy, and gene therapy.

Main Results:

• Hydrogels facilitate high drug loading and localized, sustained release.
• Hydrogel systems demonstrate tunable properties for specific therapeutic needs.
• Spatiotemporally controlled delivery via hydrogels enhances therapeutic efficacy and minimizes off-target effects.

Conclusions:

• Hydrogel technology represents a transformative approach to cancer treatment.
• Hydrogels effectively modulate the tumor microenvironment and improve antitumor efficacy.
• Further development of hydrogel-based cancer therapies holds significant promise for improved patient outcomes.